Corvus Pharmaceuticals Inc (CRVS)
Equity Ratio
94.17%
Quarterly · Period ending:
CRVS Equity Ratio
Latest reported94.17%period ending
Latest reported94.17%period ending
CRVS Quarterly Equity Ratio (78.63% → 94.17%)
Latest values, visible window
High-resolution chart · PNG
CRVS equity ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Equity Ratio |
|---|---|
| 94.1715% | |
| 95.0568% | |
| 86.06% | |
| 89.1816% | |
| 89.6793% | |
| 82.9856% | |
| 47.2637% | |
| 21.0984% | |
| 79.3451% | |
| 83.2352% | |
| 84.9209% | |
| 85.2663% | |
| 85.2553% | |
| 83.9682% | |
| 82.2318% | |
| 80.5011% | |
| 86.8653% | |
| 88.5793% | |
| 88.7689% | |
| 88.1205% | |
| 88.1246% | |
| 86.4047% | |
| 84.355% | |
| 75.8118% | |
| 79.2184% | |
| 81.3515% | |
| 85.0142% | |
| 86.9612% | |
| 86.9448% | |
| 89.6607% | |
| 93.3216% | |
| 93.417% | |
| 92.3723% | |
| 92.292% | |
| 89.512% | |
| 89.4539% | |
| 90.7306% | |
| 93.0166% | |
| 94.7563% | |
| 95.4241% | |
| 96.8436% | |
| 97.0272% | |
| -31.5878% | |
| -24.9041% | |
| 78.6336% |